Overall Fundamental outlook

|fundrankingplaceholder|
|techrankingplaceholder|

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.

Revenue projections:

Revenue projections for CLEAN
Revenue projections for CLEAN

CLEAN's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 5.01100
forwardPE 22.39752
debtToEquity 0.13500
earningsGrowth -0.21400
revenueGrowth -0.05500
grossMargins 0.62653
operatingMargins 0.30067
trailingEps 21.62000
forwardEps 33.36530

CLEAN's current ratio being 5.011 suggests that the company has no issue servicing its short-term debt. Its strong liquidity position, supported by sufficient cash reserves and current assets, ensures that CLEAN can meet its financial obligations with ease.
CLEAN's Forward PE ratio is favorable, indicating that the stock price is well-positioned in relation to its earnings. It is not overpriced, leaving room for growth, which makes it a solid option for investors seeking both stability and future appreciation.
Clean Science and Technology Limited's low growth in earnings and revenue points to a likely reduction in profits. This signals a weakening financial performance, indicating the company might face difficulties in staying profitable.
CLEAN's positive gross and operating margins highlight its strong profitability. The company's ability to control costs while generating revenue indicates efficient operations and a healthy financial position.
CLEAN's forward EPS is higher than its trailing EPS, which signals that the company is expected to achieve greater profitability this financial year. This suggests improved earnings performance, indicating a positive outlook for CLEAN's financial growth.

Price projections:

Price projections for CLEAN
Price projections for CLEAN

Price projections for Clean Science and Technology Limited have been steadily revised downward over time, indicating growing concerns about the company's future performance. This downward trend reflects reduced optimism among analysts regarding Clean Science and Technology Limited's ability to meet previous expectations.

Recommendation changes over time:

Recommendations trend for CLEAN
Recommendations trend for CLEAN


Analysts have shown a buy bias for Clean Science and Technology Limited, signaling it as a strong investment choice. This positive outlook could motivate investors to allocate funds to Clean Science and Technology Limited, seeing it as a reliable and potentially profitable option, especially in an environment where the stock market is highly scrutinized.